Literature DB >> 2370110

Immunization against chlamydial genital infection in guinea pigs with UV-inactivated and viable chlamydiae administered by different routes.

R G Rank1, B E Batteiger, L S Soderberg.   

Abstract

Female guinea pigs were immunized with viable or UV light-inactivated chlamydiae (agent of guinea pig inclusion conjunctivitis), belonging to the species Chlamydia psittaci, by intravenous, subcutaneous, oral, or ocular routes. All animals were then inoculated vaginally with viable chlamydiae to determine the extent of protection against challenge infection induced by the various regimens. The course of genital infection was significantly reduced in intensity in all groups of animals except the unimmunized controls and those animals immunized orally with inactivated antigen. Guinea pigs immunized with viable antigen were more likely to develop resistance to challenge infection and, in general, had a significantly greater degree of protection than animals immunized with inactivated antigen. No one route seemed superior in producing a protective response. Animals in all groups demonstrating protection developed serum and secretion immunoglobulin G antibody responses to chlamydiae. Lymphocyte proliferative reactions to chlamydial antigen were variable among groups. Immunoblot analysis of serum and secretions indicated a wide range of antibody specificities, but most protected animals produced antibodies to the major outer membrane protein, lipopolysaccharide, and the 61-kilodalton protein. No definitive associations could be made between the increased ability of immunization with viable organisms to produce resistance to challenge infection and a particular immune parameter. These data indicate that viable chlamydiae given by various routes are able to induce a strong immune response which can provide resistance against reinfection in some cases or at least reduce the degree of infection to a greater degree than inactivated antigen. However, complete resistance to genital tract infection may be difficult to obtain and alternate immunizations strategies may have to be developed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370110      PMCID: PMC258861          DOI: 10.1128/iai.58.8.2599-2605.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Protective role of serum antibody in immunity to chlamydial genital infection.

Authors:  R G Rank; B E Batteiger
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

2.  Induction of arthritis in C57B1/6 mice by chlamydial antigen. Effect of prior immunization or infection.

Authors:  A J Hough; R G Rank
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

3.  Specific effect of estradiol on the genital mucosal antibody response in chlamydial ocular and genital infections.

Authors:  R G Rank; A L Barron
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

4.  Animal model studies of genital chlamydial infections. Immunity to re-infection with guinea-pig inclusion conjunctivitis agent in the urethra and eye of male guinea-pigs.

Authors:  L V Howard; M P O'Leary; R L Nichols
Journal:  Br J Vener Dis       Date:  1976-08

5.  Immunologic studies in guinea pigs with guinea pig inclusion conjunctivitis (GP-IC) Bedsonia.

Authors:  E S Murray; F T Radcliffe
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

6.  Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis.

Authors:  R G Rank; H J White; A L Barron
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

7.  Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells.

Authors:  G I Byrne; J W Moulder
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

8.  Use of enteric vaccines in protection against chlamydial infections of the genital tract and the eye of guinea pigs.

Authors:  R L Nichols; E S Murray; P E Nisson
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

9.  Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis.

Authors:  B P Katz; B E Batteiger; R B Jones
Journal:  Sex Transm Dis       Date:  1987 Jul-Sep       Impact factor: 2.830

10.  Susceptibility to reinfection after a primary chlamydial genital infection.

Authors:  R G Rank; B E Batteiger; L S Soderberg
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

View more
  18 in total

1.  Host chemokine and cytokine response in the endocervix within the first developmental cycle of Chlamydia muridarum.

Authors:  Roger G Rank; H Marie Lacy; Anna Goodwin; James Sikes; Judy Whittimore; Priscilla B Wyrick; Uma M Nagarajan
Journal:  Infect Immun       Date:  2009-10-19       Impact factor: 3.441

Review 2.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

3.  Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2.

Authors:  E L Parr; M B Parr
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 4.  Animal models for studying female genital tract infection with Chlamydia trachomatis.

Authors:  Evelien De Clercq; Isabelle Kalmar; Daisy Vanrompay
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

5.  Immunity to Chlamydia trachomatis mouse pneumonitis induced by vaccination with live organisms correlates with early granulocyte-macrophage colony-stimulating factor and interleukin-12 production and with dendritic cell-like maturation.

Authors:  D Zhang; X Yang; H Lu; G Zhong; R C Brunham
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.

Authors:  Rhea N Coler; Ajay Bhatia; Jean-Francois Maisonneuve; Peter Probst; Brenda Barth; Pamela Ovendale; Hang Fang; Mark Alderson; Yves Lobet; Joe Cohen; Pascal Mettens; Steven G Reed
Journal:  FEMS Immunol Med Microbiol       Date:  2009-03

Review 7.  Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection.

Authors:  Roger G Rank; Laxmi Yeruva
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

8.  Characterization of chlamydial genital infection resulting from sexual transmission from male to female guinea pigs and determination of infectious dose.

Authors:  Roger G Rank; Anne K Bowlin; Ronald L Reed; Toni Darville
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones.

Authors:  J U Igietseme; D M Magee; D M Williams; R G Rank
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

Review 10.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.